Literature DB >> 28111968

First high-risk percutaneous coronary intervention under use of the iVAC2l system in Germany.

Alexander Samol1, Stefanie Schmidt1, Melanie Zeyse1, Stefanie Dürrwald1, Marcus Wiemer1.   

Abstract

Percutaneous coronary intervention of complex stenoses is becoming more and more of an alternative to coronary bypass surgery. Nevertheless, complications can occur and lead to the need for circulatory support and/or emergency surgery. Circulatory support devices like the intra-aortic balloon pump showed only low benefit in patients' outcome. Devices with higher cardiac output necessitate more complex implantation procedures. We report the case of the first successful use of a transfemoral pulsatile ventricular assist device with up to 2 l additional cardiac output during high-risk percutaneous coronary intervention in a 74-year-old man with complex stenosis. The device was safe and feasible during coronary intervention in its use. Its beneficial effect on hemodynamics and patients' outcome has to be evaluated in larger multicenter studies.

Entities:  

Keywords:  circulatory support; high-risk PCI; left ventricular assist device

Mesh:

Year:  2017        PMID: 28111968     DOI: 10.2217/fca-2016-0064

Source DB:  PubMed          Journal:  Future Cardiol        ISSN: 1479-6678


  2 in total

1.  First successful prevention of cardiopulmonary resuscitation during high-risk percutaneous coronary intervention by use of a pulsatile left ventricular assist device: baptism of fire of the iVAC2L device: a case report.

Authors:  Alexander Samol; Stefanie Schmidt; Melanie Zeyse; Marcus Wiemer
Journal:  Eur Heart J Case Rep       Date:  2018-01-24

2.  Effectiveness and Safety of a Prolonged Hemodynamic Support by the IVAC2L System in Healthy and Cardiogenic Shock Pigs.

Authors:  Clément Delmas; Jean Porterie; Géraldine Jourdan; Frank Lezoualc'h; Romain Arnaud; Stéphanie Brun; Hugo Cavalerie; Grégoire Blanc; Bertrand Marcheix; Olivier Lairez; Patrick Verwaerde; Jeanne Mialet-Perez
Journal:  Front Cardiovasc Med       Date:  2022-02-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.